136 related articles for article (PubMed ID: 20814808)
1. (E)-N-[(3,4-dimethoxyphenethyl)]-N-methyl-3-(3-pyridyl)-2-propenamide (TJN-331) inhibits mesangial expansion in experimental IgA nephropathy in ddY mice.
Saegusa Y; Sadakane C; Koseki J; Hasegawa Y; Shindo S; Takeda S; Takeda H; Hattori T
Clin Exp Nephrol; 2010 Dec; 14(6):528-35. PubMed ID: 20814808
[TBL] [Abstract][Full Text] [Related]
2. TJN-259 improves mesangial lesions in experimental immunoglobulin A nephropathy in ddY mice.
Sadakane C; Hattori T; Koseki J; Inagaki Y; Hasegawa Y; Shindo S; Takeda S; Takeda H
Biol Pharm Bull; 2009 Oct; 32(10):1728-33. PubMed ID: 19801835
[TBL] [Abstract][Full Text] [Related]
3. TJN-331 improves anti-glomerular basement membrane nephritis by inhibiting the production of intraglomerular transforming growth factor-beta1.
Saegusa Y; Sadakane C; Koseki J; Hasegawa Y; Shindo S; Maruyama H; Takeda S; Takeda H; Hattori T
Biol Pharm Bull; 2010; 33(8):1349-54. PubMed ID: 20686230
[TBL] [Abstract][Full Text] [Related]
4. Effect of TJN-331 on anti-Thy1 nephritis in rats via inhibition of transforming growth factor-β1 production.
Saegusa Y; Sadakane C; Koseki J; Hasegawa Y; Shindo S; Maruyama H; Kase Y; Takeda S; Takeda H; Hattori T
Biol Pharm Bull; 2010; 33(10):1710-5. PubMed ID: 20930380
[TBL] [Abstract][Full Text] [Related]
5. Effects of TJN-598, a new selective phosphodiesterase type IV inhibitor on anti-Thy1 nephritis in rats.
Sadakane C; Kase Y; Koseki J; Hasegawa Y; Shindo S; Maruyama H; Takeda S; Takeda H; Hattori T
Clin Exp Nephrol; 2011 Feb; 15(1):14-24. PubMed ID: 20820840
[TBL] [Abstract][Full Text] [Related]
6. Role of transforming growth factor-beta 1 and -beta 2 in ddY mouse nephropathy.
Ye XF; Yorioka N; Oda H; Taniguchi Y; Yamakido M
J Int Med Res; 1997; 25(3):141-54. PubMed ID: 9178146
[TBL] [Abstract][Full Text] [Related]
7. The study of Chinese medicinal herbal formula Shen San Fang in the treatment of experimental IgA nephropathy.
Zhong Q; Leung JC; Chan LY; Tsang AW; Chen X; Lai KN
Am J Chin Med; 2005; 33(4):613-26. PubMed ID: 16173535
[TBL] [Abstract][Full Text] [Related]
8. IgA nephropathy: lessons from an animal model, the ddY mouse.
Tomino Y
J Nephrol; 2008; 21(4):463-7. PubMed ID: 18651534
[TBL] [Abstract][Full Text] [Related]
9. Enhanced production of glomerular extracellular matrix in a new mouse strain of high serum IgA ddY mice.
Muso E; Yoshida H; Takeuchi E; Yashiro M; Matsushima H; Oyama A; Suyama K; Kawamura T; Kamata T; Miyawaki S; Izui S; Sasayama S
Kidney Int; 1996 Dec; 50(6):1946-57. PubMed ID: 8943478
[TBL] [Abstract][Full Text] [Related]
10. IgA deposits might not influence the production of extracellular matrix in glomeruli of ddY mice, a spontaneous animal model for IgA nephropathy.
Tsushima Y; Tomino Y; Shimizu M; Ohmuro H; Takeuchi K; Kuramoto T; Shirato I; Koide H
Nephron; 1994; 66(1):81-6. PubMed ID: 7906404
[TBL] [Abstract][Full Text] [Related]
11. Effect of monoclonal antibody CD4 on glomerulonephritis of ddY mice, a spontaneous animal model of IgA nephropathy.
Tomino Y; Shimizu M; Koide H; Abe M; Shirai T
Am J Kidney Dis; 1993 Apr; 21(4):427-32. PubMed ID: 8096678
[TBL] [Abstract][Full Text] [Related]
12. Effect of IgA aggregates on transforming growth factor-beta1 production in human mesangial cells and the intraglomerular expression of transforming growth factor-beta1 in patients with IgA nephropathy.
Han SY; Ihm CG; Cha DR; Kang YS; Han KH; Kim HK; Han JY
Korean J Intern Med; 2005 Mar; 20(1):40-7. PubMed ID: 15906952
[TBL] [Abstract][Full Text] [Related]
13. Mesangial cells stimulated by immunoglobin A1 from IgA nephropathy upregulates transforming growth factor-beta1 synthesis in podocytes via renin-angiotensin system activation.
Wang C; Liu X; Peng H; Tang Y; Tang H; Chen Z; Lou T; Zhang H
Arch Med Res; 2010 May; 41(4):255-60. PubMed ID: 20637368
[TBL] [Abstract][Full Text] [Related]
14. Effect of monoclonal antibody CD4 on expression of intercellular adhesion molecule 1 in renal tissues of ddY mice: a spontaneous animal model of IgA nephropathy.
Ohmuro H; Tomino Y; Koide H
Am J Nephrol; 1994; 14(2):136-41. PubMed ID: 7915884
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 4 is involved in a protective effect of rhein on immunoglobulin A nephropathy.
Chen X; Peng S; Zeng H; Fu A; Zhu Q
Indian J Pharmacol; 2015; 47(1):27-33. PubMed ID: 25821307
[TBL] [Abstract][Full Text] [Related]
16. Roles of TGF-beta1 and apoptosis in the progression of glomerulosclerosis in human IgA nephropathy.
Chihara Y; Ono H; Ishimitsu T; Ono Y; Ishikawa K; Rakugi H; Ogihara T; Matsuoka H
Clin Nephrol; 2006 Jun; 65(6):385-92. PubMed ID: 16792132
[TBL] [Abstract][Full Text] [Related]
17. Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy.
Leung JC; Chan LY; Tsang AW; Liu EW; Lam MF; Tang SC; Lai KN
Nephrol Dial Transplant; 2004 Aug; 19(8):1976-85. PubMed ID: 15187193
[TBL] [Abstract][Full Text] [Related]
18. Effect of steroid-liposome on immunohistopathology of IgA nephropathy in ddY mice.
Liao J; Hayashi K; Horikoshi S; Ushijima H; Kimura J; Tomino Y
Nephron; 2001 Oct; 89(2):194-200. PubMed ID: 11549902
[TBL] [Abstract][Full Text] [Related]
19. Up-regulated TGF-beta mRNA expression in splenic T cells of high IgA-prone mice: a murine model of IgA nephropathy with glomerulosclerosis.
Oyama A; Muso E; Ono T; Matsushima H; Yashiro M; Suyama K; Kamata T; Nogaki F; Kobayashi I; Miyawaki S; Yoshida H; Sasayama S
Nephron; 2001 Aug; 88(4):368-75. PubMed ID: 11474233
[TBL] [Abstract][Full Text] [Related]
20. Effect of mizoribine on glomerulonephritis of early-stage IgA nephropathy in ddY mice.
Shimizu M; Shou I; Tsuge T; Abe M; Tomino Y
Nephron; 1998; 79(1):67-72. PubMed ID: 9609465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
